Autonomix medical, inc. granted new u.s. patent to advance minimally invasive, nerve-focused treatments across high-need indications

With over 80 issued patents and 40 pending patent applications, autonomix is building a comprehensive ip portfolio in nerve-sensing and modulation, strengthening its strategic position in a multi-billion-dollar market opportunity and unlocking potential across cardiovascular, renal, and other high-burden diseases
AMIX Ratings Summary
AMIX Quant Ranking